Background and Aim: A reliable classification for predicting postoperative prognosis
| INTRODUCTION
Hepatocellular carcinoma (HCC) is a lethal disease and the second leading cause of cancer death worldwide. 1 For curative treatment of HCC, hepatectomy (hepatic resection) is a major and desirable strategy. [2] [3] [4] However, even after curative hepatectomy, 80% of patients develop HCC recurrence in the remnant liver and 50% die within 5 years. 5 Hetero chronological multiple HCC occurrences are generally associated with background hepatitis caused by virus, alcohol, and non-alcoholic fatty liver disease 6 whereas intrahepatic tumor metastasis is mainly attributed to invasiveness of primary loci and relatively early recurrence. 7 According to these two types of hepatic recurrence, both background liver status and tumor factor of HCC should be considered to make a precise decision for HCC treatment.
Currently, the American Joint Committee on Cancer (AJCC)/ Union for International Cancer Control (UICC) tumor-node-metastasis (TNM) staging system is commonly used for evaluating pretreatment tumor status, and Child-Pugh (CP) classification is applied for evaluating background liver status. 8 However, as previously mentioned, CP classification and the integrated scoring system using CP classification have several limitations as a result of including subjective values such as grading of ascites and hepatic encephalopathy. 9 Indocyanine green (ICG) testing is usually carried out prior to HCC treatment for assessing background liver status especially in Asian countries and in several institutes in Europe. 9, 10 Although ICG testing well reflects the liver function, this examination requires well-organized preparation to obtain an accurate result such as preexamination bed-rest whether or not using an ICG clearance meter that does not require multiple blood sampling. Hence, a simple and accurate way to evaluate both tumor and background liver status of HCC prior to treatment has been strongly desired.
Lately, albumin-bilirubin (ALBI) grade 11 and ALBI-TNM (ALBI-T) score 12 have attracted clinicians' attention as more convenient and precise methods to evaluate HCC and background liver. Although there are some important studies showing the prognostic impact of ALBI grade and ALBI-T score on HCC treatment, 11, 12 their actual significance to HCC surgery is still being considered. In the present study, we retrospectively assessed the usefulness of ICG testing, TNM stage of the Liver Cancer Study Group of Japan (LCSGJ), 13 ALBI grade, and ALBI-T score to predict HCC prognosis after hepatectomy and to evaluate the risk at hepatectomy by conducting a search of consecutive resected HCC cases from our institute.
| ME TH ODS

| Patients enrolled in the present study
Between January 1998 and December 2012, 273 consecutive patients who underwent curative hepatectomy for HCC at the Department of Gastroenterological Surgery, Nagoya University Hospital (Nagoya, Japan) were identified. The 235 cases identified as CP class A were enrolled in this study. Written informed consent, as required by the Institutional Review Board, was obtained from all patients for use of the anonymized information. whereas the other pathological variables were categorized as positive or negative, as described by the guidelines of the LCSGJ. 13 We used the definition of the Clavien-Dindo classification to assess postoperative ascites, pleural effusion, bile leakage, and surgical site infection and grade IIIa or greater was considered positive. 17 As for postoperative liver failure, we referred to the grading by the International Study Group of Liver Surgery and, in the present study, grade B and C were considered positive. 
| Clinical examination and hepatectomy
| Follow up after surgery
After discharge, patients were followed up once per month for 3 months and every 3 months thereafter. Blood examination, including those for serum AFP and des-gamma-carboxy prothrombin, was carried out at every outpatient care visit, and dynamic contrastenhanced CT was done every 6 months. Patients with abnormal data or suspected lesions underwent further examinations, including contrast ultrasonography, magnetic resonance imaging with gadoliniumethoxybenzyl-diethylenetriamine pentaacetic acid, CT with hepatic arterioportography, and/or positron emission tomography for the diagnosis of HCC recurrence.
| Classifications
Albumin-bilirubin score was calculated and patients were classified with the cut-off points as previously reported. Guidelines by LCSGJ. 13 T factor for TNM stage of LCSGJ is as shown in Table S1 . ALBI-T score was calculated using the following equation: ALBI-T score = ALBI grade + TNM stage of LCSGJ − 2. 
| Statistical analysis
All statistical analyses were carried out using R version 3. Meier method and log-rank tests was also carried out. The level of statistical significance was set at P < 0.05, which was obtained using two-tailed tests.
| RESULTS
| Patient characteristics
In the present study, 235 CP class A HCC patients were enrolled, as other classes (B and C) of CP classification were rare in the patients who underwent hepatectomy and the class B cases were hypothesized to have worse prognosis than grade A. 19 Patient demographic and clinical characteristics are shown in Table 1 | 67 (P < 0.0001) as well as Alb concentration (<3.5 or ≥3.5, P < 0.0001) and liver damage score (A or B, C, <0.0001, Table S2 ) defined by presence of ascites, T-bil concentration, Alb concentration, ICG-R15, and PT. 11 As for ALBI-T score, the proportion of patients was significantly different according to gender (P = 0.03), Alb concentration (P = 0.01), number of tumors (multiple or solitary, P < 0.0001), tumor size (<2 or ≥2 cm, P = 0.003), growth form (expansive or infiltrative, P = 0.001), serosal invasion (P = 0.003), vascular invasion (P < 0.0001), and stage (<III or ≥III, P < 0.0001, Table S3 ).
| Association among ALBI grade, ALBI-T score, and ICG-R15
In 154 informative cases with ICG-R15, a significant difference of ICG-R15 value could be identified between ALBI grade 1 and ALBI grade 2 (P < 0.0001, Figure 1C ) although there was no significant difference of ICG-R15 between ALBI-T 0,1,2 and ALBI-T 3,4
(P = 0.96, Figure 1D ). In addition, correlation analysis showed that the value of a linear predictor for ALBI grade (xb) was moderately correlated with ICG-R15 (r = 0.51, P < 0.0001, Figure 1E ). The (Table S4 ). According to this analysis, stage was associated with pleural effusion (P < 0.0001); ALBI grade was associated with persistent ascites (P = 0.002); and ALBI-T score was associated with both ascites and pleural effusion (P = 0.04 and 0.0003). Consequently, these results indicate that ALBI-T score has a capability of predicting operation time, IOBL, and postoperative complications preoperatively as well as predicting postoperative prognosis.
| DISCUSSION
In this study, we evaluated perioperative clinical importance of ICG-R15, stage, ALBI grade, and ALBI-T score in CP class A patients who underwent hepatectomy for HCC. Because most of the patients who undergo hepatectomy are CP class A, we focused only on CP class A patients in the present study. Our findings suggested that ALBI grade correlates well with ICG-R15 reflecting the background liver function. In addition, ALBI-T score was a robust predictor for both RFS and OS in CP class A patients after hepatectomy. Furthermore, ALBI-T score or ALBI grade was significantly associated with operation time, IOBL, and need for intraoperative transfusion. Consequently, ALBI-T score is capable of assessing the preoperative risk and patients' prognosis after hepatectomy. Currently, thanks to achievements made by our predecessors, the safety and feasibility of hepatectomy have been greatly improved. However, a report by the National Clinical Database group in Japan showed that the rate of mortality at hepatectomy and at 30 days postoperatively was still 2.3% and 1.3%, respectively, in 2016. 21 We believe that even among patients diagnosed with relatively well-preserved hepatic function (CP class A), some might be better off undergoing non-surgical treatment. We believe that precise evaluation prior to surgery is essential to achieve patients' maximum benefit. Thus, ALBI grade and ALBI-T are potentially capable of contributing to precision treatment for HCC patients. The poor prognosis and high frequency of HCC recurrence is associated with both tumor factors and background liver status. 23 To deliver a desired precision treatment to HCC patients, estimating the prognosis of patients planning to undergo hepatectomy is essential.
Furthermore, hepatectomy has a potential risk of massive bleeding requiring blood transfusion that causes severe complications such as hepatic failure after surgery. 24 To avoid perioperative fatality, evaluating background liver status and developing an appropriate strategy are also crucial. Thus, in terms of the unique aspects of prognosis and operative risk of HCC, we compared ICG-R15, stage, ALBI grade, and ALBI-T score and finally shed light on the superiority of ALBI-T comprising both tumor features and background liver status.
Tumor staging is generally needed to determine the patients' survival probability after treatment, decide the most appropriate therapy, and enable an objective comparison among the outcomes of cancer research. Furthermore, it should allow us to predict the prognosis of resected cancer cases and individual treatment risk. For these reasons, staging systems should separate patients into groups with homogeneous prognosis, and serve to select the appropriate treatment. 25 The AJCC/UICC TNM staging system for HCC incorporates tumor size and local invasiveness such as vascular invasion, and number of tumor nodules as well as lymph node and distant metastasis. 8 As for various types of neoplasms, the TNM staging system is a reliable outcome predictor, but prognostic modeling in HCC is more complex than those in other gastrointestinal cancers. There Cancer of the Liver Italian Program, 27 Barcelona Clinic Liver Cancer staging, 28 the Chinese University Prognostic Index, 29 and staging according to the guidelines of the LCSGJ. 13 However, none of these classifications has received universal acceptance. 30 One of the reasons why HCC staging is difficult is its characteristic recurrence has not yet reached liver cirrhosis. 33 Thus, background liver status as well as HCC tumor itself should be accurately estimated and classified to minimize the potential risk in hepatectomy and to identify the individual benefit of surgery. The current study showed that ALBI-T score was significantly associated with both operation time and IOBL and that ALBI grade was associated with intraoperative transfusion. With a further validation study, these characteristics of ALBI grade and ALBI-T score could be useful for surgeons preparing for a hepatectomy. Yasuhiro Kodera http://orcid.org/0000-0002-6173-7474
